Frontiers in Neurology (Nov 2022)
Data-driven clustering of combined Functional Motor Disorders based on the Italian registry
- Giovanni Mostile,
- Giovanni Mostile,
- Christian Geroin,
- Roberto Erro,
- Antonina Luca,
- Enrico Marcuzzo,
- Paolo Barone,
- Roberto Ceravolo,
- Sonia Mazzucchi,
- Andrea Pilotto,
- Andrea Pilotto,
- Alessandro Padovani,
- Luigi Michele Romito,
- Roberto Eleopra,
- Carlo Dallocchio,
- Carla Arbasino,
- Francesco Bono,
- Pietro Antonio Bruno,
- Benedetta Demartini,
- Orsola Gambini,
- Nicola Modugno,
- Enrica Olivola,
- Laura Bonanni,
- Laura Bonanni,
- Alberto Albanese,
- Gina Ferrazzano,
- Rosa De Micco,
- Maurizio Zibetti,
- Giovanna Calandra-Buonaura,
- Giovanna Calandra-Buonaura,
- Martina Petracca,
- Francesca Morgante,
- Francesca Morgante,
- Marcello Esposito,
- Marcello Esposito,
- Antonio Pisani,
- Antonio Pisani,
- Paolo Manganotti,
- Fabrizio Stocchi,
- Mario Coletti Moja,
- Ilaria Antonella Di Vico,
- Lucia Tesolin,
- Francesco De Bertoldi,
- Tommaso Ercoli,
- Giovanni Defazio,
- Mario Zappia,
- Alessandra Nicoletti,
- Michele Tinazzi
Affiliations
- Giovanni Mostile
- Section of Neurosciences, Department “G.F. Ingrassia”, University of Catania, Catania, Italy
- Giovanni Mostile
- Oasi Research Institute—IRCCS, Troina, Italy
- Christian Geroin
- Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Roberto Erro
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry—Scuola Medica Salernitana, University of Salerno, Baronissi, Italy
- Antonina Luca
- Section of Neurosciences, Department “G.F. Ingrassia”, University of Catania, Catania, Italy
- Enrico Marcuzzo
- Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Paolo Barone
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry—Scuola Medica Salernitana, University of Salerno, Baronissi, Italy
- Roberto Ceravolo
- Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Sonia Mazzucchi
- Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Andrea Pilotto
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Andrea Pilotto
- FERB Onlus, Ospedale S. Isidoro, Bergamo, Italy
- Alessandro Padovani
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Luigi Michele Romito
- Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Roberto Eleopra
- Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Carlo Dallocchio
- Department of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy
- Carla Arbasino
- Department of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy
- Francesco Bono
- 0Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy
- Pietro Antonio Bruno
- 0Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy
- Benedetta Demartini
- 1Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy
- Orsola Gambini
- 1Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy
- Nicola Modugno
- 2IRCCS Neuromed, Pozzilli, Italy
- Enrica Olivola
- 2IRCCS Neuromed, Pozzilli, Italy
- Laura Bonanni
- 3Department of Medicine and Aging Sciences, University G. d'Annunzio, Chieti, Italy
- Laura Bonanni
- 4Department of Medicine and Aging Sciences, University G. d'Annunzio, Pescara, Italy
- Alberto Albanese
- 5IRCCS Humanitas Research Hospital, Milan, Italy
- Gina Ferrazzano
- 6Department of Human Neurosciences, Università La Sapienza, Rome, Italy
- Rosa De Micco
- 7Department of Advanced Medical and Surgery Sciences, University of Campania—Luigi Vanvitelli, Naples, Italy
- Maurizio Zibetti
- 8Department of Neuroscience—Rita Levi Montalcini, University of Turin, Turin, Italy
- Giovanna Calandra-Buonaura
- 9Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
- Giovanna Calandra-Buonaura
- 0IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy
- Martina Petracca
- 1Movement Disorder Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Francesca Morgante
- 2Neurosciences Research Centre, Molecular and Clinical Sciences Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom
- Francesca Morgante
- 3Department of Experimental and Clinical Medicine, University of Messina, Messina, Italy
- Marcello Esposito
- 4Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy
- Marcello Esposito
- 5Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples—Federico II, Naples, Italy
- Antonio Pisani
- 6IRCCS Mondino Foundation, Pavia, Italy
- Antonio Pisani
- 7Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- Paolo Manganotti
- 8Clinical Neurology Unit, Department of Medical, Surgical and Health Services, University of Trieste, Trieste, Italy
- Fabrizio Stocchi
- 9University and Institute of Research and Medical Care San Raffaele, Rome, Italy
- Mario Coletti Moja
- 0Ospedale degli Infermi, Biella, Italy
- Ilaria Antonella Di Vico
- Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Lucia Tesolin
- 1Psichiatria, Ospedale San Maurizio, Bolzano, Italy
- Francesco De Bertoldi
- 1Psichiatria, Ospedale San Maurizio, Bolzano, Italy
- Tommaso Ercoli
- 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
- Giovanni Defazio
- 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
- Mario Zappia
- Section of Neurosciences, Department “G.F. Ingrassia”, University of Catania, Catania, Italy
- Alessandra Nicoletti
- Section of Neurosciences, Department “G.F. Ingrassia”, University of Catania, Catania, Italy
- Michele Tinazzi
- Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- DOI
- https://doi.org/10.3389/fneur.2022.987593
- Journal volume & issue
-
Vol. 13
Abstract
IntroductionFunctional Motor Disorders (FMDs) represent nosological entities with no clear phenotypic characterization, especially in patients with multiple (combined FMDs) motor manifestations. A data-driven approach using cluster analysis of clinical data has been proposed as an analytic method to obtain non-hierarchical unbiased classifications. The study aimed to identify clinical subtypes of combined FMDs using a data-driven approach to overcome possible limits related to “a priori” classifications and clinical overlapping.MethodsData were obtained by the Italian Registry of Functional Motor Disorders. Patients identified with multiple or “combined” FMDs by standardized clinical assessments were selected to be analyzed. Non-hierarchical cluster analysis was performed based on FMDs phenomenology. Multivariate analysis was then performed after adjustment for principal confounding variables.ResultsFrom a study population of n = 410 subjects with FMDs, we selected n = 188 subjects [women: 133 (70.7%); age: 47.9 ± 14.4 years; disease duration: 6.4 ± 7.7 years] presenting combined FMDs to be analyzed. Based on motor phenotype, two independent clusters were identified: Cluster C1 (n = 82; 43.6%) and Cluster C2 (n = 106; 56.4%). Cluster C1 was characterized by functional tremor plus parkinsonism as the main clinical phenotype. Cluster C2 mainly included subjects with functional weakness. Cluster C1 included older subjects suffering from anxiety who were more treated with botulinum toxin and antiepileptics. Cluster C2 included younger subjects referring to different associated symptoms, such as pain, headache, and visual disturbances, who were more treated with antidepressants.ConclusionUsing a data-driven approach of clinical data from the Italian registry, we differentiated clinical subtypes among combined FMDs to be validated by prospective studies.
Keywords
- cluster analysis
- clinical phenotypes
- Functional Motor Disorders
- data-driven phenotyping
- functional neurological disorder